Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-03

Clinical Trial Update: A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sulfamethoxazole-trimethoprim to aerosolized pentamidine for secondary prophylaxis of Pneumocystis jirovecii pneumonia in AIDS patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aerosolized pentamidine (pentamidine)
  • Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED